Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2013
01/24/2013US20130022999 Protein fragment complementation assays for the detection of biological or drug interactions
01/24/2013US20130022998 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer
01/24/2013US20130022997 Monoclonal antibody against pbp2a derived from mrsa with dual binding activities
01/24/2013US20130022996 Genetically modified mice and engraftment
01/24/2013US20130022995 Metal nanowire including gold nanoclusters on a surface thereof for binding target material and method of binding the target material to the metal nanowire
01/24/2013US20130022994 Regulation of bace degradation
01/24/2013US20130022993 Compound, phosphorylation inhibitor, insulin resistance improving agent, preventive or therapeutic agent for diabetes, and screening method
01/24/2013US20130022992 In vitro assay for quantifying clostridial neurotoxin activity
01/24/2013US20130022991 Cell free cd4 quantitation and methods of use
01/24/2013US20130022990 Cellular labeling for nuclear magnetic resonance techniques
01/24/2013US20130022989 Dental stem cell reprogramming
01/24/2013US20130022987 Method for Diagnosing or Determining the Prognosis of Colorectal Cancer (CRC) Using Novel Autoantigens: Gene Expression Guided Autoantigen Discovery
01/24/2013US20130022984 Method for the non-specific enrichment of microorganisms
01/24/2013US20130022983 Colon and Rectal Tumor Markers and Methods of Use Thereof
01/24/2013US20130022982 Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
01/24/2013US20130022981 Novel human lysosomal protein and methods of its use
01/24/2013US20130022978 Measurement of Brain CDP-Diacylglycerol Synthase 1 Enzyme and Uses Thereof
01/24/2013US20130022967 NUCLEIC ACID MOLECULE HAVING AFFINITY TO RODENT-DERIVED IgG ANTIBODY, BINDER, DETECTION REAGENT, AND DETECTION KIT
01/24/2013US20130022966 Methods of Treating Cancer Using Notch Pathway Inhibitors
01/24/2013US20130022965 Test system for visual analysis
01/24/2013US20130022960 Rapid test for detecting infection
01/24/2013US20130022718 Method for Producing Hypoallergenic Peanut Products
01/24/2013US20130022716 Process and double piston apparatus for controlling the preparation of beverages
01/24/2013US20130022623 Antibodies that specifically bind to tim3
01/24/2013US20130022622 Compounds for the treatment of autism
01/24/2013US20130022620 Assays and methods pertaining to pre-amyloid intermediates
01/24/2013US20130022617 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
01/24/2013US20130022616 Interleukin-31 Monoclonal Antibody
01/24/2013US20130022611 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
01/24/2013US20130022608 FULL-LENGTH IgG IMMUNOGLOBULINS CAPABLE OF RECOGNIZING A HETEROSUBTYPE NEUTRALIZING EPITOPE ON THE HEMAGGLUTININ STEM REGION AND USES THEREOF
01/24/2013US20130022607 Mucosal vascular addressins and uses thereof
01/24/2013US20130022598 Dual Specific Immunotoxin for Brain Tumor Therapy
01/24/2013US20130022593 Methods of diagnosing endometriosis
01/24/2013US20130022586 Production and use of bacterial histamine
01/24/2013US20130022583 Direct Conversion of Cells to Cells of Other Lineages
01/24/2013US20130022549 Halogenated phenols for diagnostics, antioxidant protection and drug delivery
01/24/2013US20130022547 Attenuated mycoplasma gallisepticum strains
01/24/2013US20130022546 Peptides that Specifically Target Amyloid Deposits
01/24/2013US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
01/24/2013US20130022539 Ovr115 antibody compositions and methods of use
01/24/2013US20130020263 Parallel separation system
01/24/2013US20130020208 Method of measuring quantity of substrate
01/24/2013US20130019665 Testing of Concrete Using Existing Voids Within Concrete
01/24/2013DE19945553B4 Verfahren zum Nachweis von mindestens einer multiresistenten Keimart, insbesondere MRSA- und VRE-Keimen Method for the detection of at least one multi-resistant germ, especially MRSA and VRE germs
01/24/2013DE102011108360A1 Biochip, which is based on silicon, and is manufactured in photolithography and etching technology, useful in biological and medical analysis, comprises many individual wells applied on top silicon-, silicon dioxide- or metal oxide-layer
01/24/2013DE102011108251A1 Inducing nucleation in sample, preferably biological sample, using external element, comprises providing sample in freezing chamber, providing external element, and cooling and determining temperature of sample in freezing chamber
01/24/2013DE102011107899A1 Method for classification of round timber with wood moisture measuring device for masts, particularly for line construction, involves introducing pin, particularly metal pin with predetermined penetration depth into round timber
01/24/2013DE102011079661A1 Verfahren zur individualisierten Haarbehandlung A method for individualized hair treatment
01/24/2013DE102010027074B4 Verfahren und Vorrichtung zur Detektion von Sprengstoffpartikeln in einem Gasstrom Method and apparatus for detecting explosive particles in a gas stream
01/24/2013DE102006030566B4 Verfahren und Reagenzien zur Diagnose entzündlicher Lebererkrankungen Methods and reagents for diagnosis of inflammatory liver disease
01/24/2013CA2877994A1 Targeted osmotic lysis of cancer cells
01/24/2013CA2857493A1 Combinations of fluorphores and pyridinium boronic acid quenchers for use in analyte sensors
01/24/2013CA2856355A1 Device and system for gas leakage detection and alarm
01/24/2013CA2842682A1 Methods for determining patient response to anti-platelet aggregation therapy
01/24/2013CA2842681A1 Instrument and method for optical particle sensing
01/24/2013CA2842679A1 Assay to capture and detect circulating multiple myeloma cells from blood
01/24/2013CA2842475A1 Interleukin-31 monoclonal antibody
01/24/2013CA2842379A1 Production and use of bacterial histamine
01/24/2013CA2842321A1 Engineered microbe-targeting molecules and uses thereof
01/24/2013CA2842268A1 Biomarkers for ankylosing spondylitis
01/24/2013CA2842068A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira
01/24/2013CA2841745A1 Rspo binding agents and uses thereof
01/24/2013CA2841725A1 Anti-folate receptor alpha antibodies and uses thereof
01/24/2013CA2840797A1 Diagnosis of alzheimer's disease
01/24/2013CA2823788A1 Compensated patch-clamp amplifier for nanopore polynucleotide sequencing and other applications
01/24/2013CA2823787A1 Dual-pore device
01/23/2013EP2549276A2 Reversible covalent linkage of functional molecules
01/23/2013EP2549275A1 Information acquisition device, measurement system, and information acquisition method
01/23/2013EP2549272A1 Method and apparatus for evaluation of standing timber
01/23/2013EP2549270A2 Biosensor desiccant system having enhanced measurement performance
01/23/2013EP2549269A1 Microfluidic detection of analytes
01/23/2013EP2549262A1 Machine to perform tests on materials
01/23/2013EP2548959A1 Florigen-activating complex
01/23/2013EP2548888A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same
01/23/2013EP2548849A1 Process for controlling and monitoring the production of biogas
01/23/2013EP2548708A2 Concrete mixer truck
01/23/2013EP2548583A2 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen
01/23/2013EP2548577A1 Human anti-il-23 antibodies, compositions, methods and uses
01/23/2013EP2548576A1 Diagnosis of cancer using anti-desmoglein-3 antibodies
01/23/2013EP2548505A1 Water vapour sensor
01/23/2013EP2548031A2 Molecular markers for urinary tract infections
01/23/2013EP2548030A2 Engineering correctly folded antibodies using inner membrane display of twin-arginine translocation intermediates
01/23/2013EP2548028A1 Flc as biomarker
01/23/2013EP2548027A2 Method for predicting the responsiveness to chemotherapy
01/23/2013EP2548026A1 Detection of overtraining syndrome in an individual
01/23/2013EP2548025A2 Using phage epitopes to profile the immune response
01/23/2013EP2548024A2 Arsenical fluorescent agents and assays
01/23/2013EP2548023A1 Device and method for manipulating or analysing a liquid sample
01/23/2013EP2548022A2 Multiphase microarrays and uses thereof
01/23/2013EP2548021A2 Method for determining substance non-toxicity
01/23/2013EP2548020A1 Method for detection of inflammation in the urinary tract or urethra
01/23/2013EP2548019A1 In vitro process for the quick determination of a patient's status relating to infection with mycobacterium tuberculosis
01/23/2013EP2548018A1 Determining susceptibility to a sudden cardiac event
01/23/2013EP2548017A2 Small molecule inhibitors of muc1 and methods of identifying the same
01/23/2013EP2548016A1 Method and device for characterizing sensory properties of fabrics
01/23/2013EP2548015A1 Improved mass spectrometric assays for peptides
01/23/2013EP2548014A1 Biosensor on thin-film transistors
01/23/2013EP2548005A1 Photoluminescent analyte partial volume probe set
01/23/2013EP2547999A1 Clearing reagent for biological material, and use thereof
01/23/2013EP2547791A2 Comparative genomic hybridization array method for preimplantation genetic screening